| Life Care Center Of Attleboro | |
| 969 Park Street, Attleboro, Massachusetts 02703 | |
| (508) 222-4182 | |
| Name | Life Care Center Of Attleboro |
|---|---|
| Location | 969 Park Street, Attleboro, Massachusetts |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 123 |
| Occupancy Rate | 82.85% |
| Medicare ID (CCN) | 225564 |
| Legal Business Name | Attleboro Medical Investors Lp |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1225091770 |
| Organization Name | ATTLEBORO MEDICAL INVESTORS LP |
| Doing Business As | LIFE CARE CENTER OF ATTLEBORO |
| Address | 969 Park St, Attleboro, MA 02703 |
| Phone Number | 508-222-4182 |
News Archive
Acerde, an innovative company specializing in the development of rotating anodes for X-ray tubes used in the medical imaging industry, today announced (i) the signature of a development contract with a major China-based player in medical imaging, (ii) its achievement of a number of industrial development milestones and (iii) the preparation of the company's next generation of highly innovative rotating anodes (which are now composite-based rather than graphite-based).
B. Braun Medical Inc. (B. Braun) has announced an expanded agreement with HealthTrust Purchasing Group (HealthTrust) to provide pain management products to HealthTrust's membership.
OncoGenex Pharmaceuticals, Inc. announced today that it has initiated patient enrollment in a randomized, Phase II clinical trial evaluating OGX-427, an inhibitor of heat shock protein 27 (Hsp27), in patients with advanced bladder cancer.
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Acerde, an innovative company specializing in the development of rotating anodes for X-ray tubes used in the medical imaging industry, today announced (i) the signature of a development contract with a major China-based player in medical imaging, (ii) its achievement of a number of industrial development milestones and (iii) the preparation of the company's next generation of highly innovative rotating anodes (which are now composite-based rather than graphite-based).
B. Braun Medical Inc. (B. Braun) has announced an expanded agreement with HealthTrust Purchasing Group (HealthTrust) to provide pain management products to HealthTrust's membership.
OncoGenex Pharmaceuticals, Inc. announced today that it has initiated patient enrollment in a randomized, Phase II clinical trial evaluating OGX-427, an inhibitor of heat shock protein 27 (Hsp27), in patients with advanced bladder cancer.
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 11.18 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 3.49 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 75.17 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.32 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.5 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 4.58 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.59 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 95.03 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 4.84 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 95.16 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.34 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 24.68 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.81 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.2 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.09 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 54.72 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 89.32 | 82.93 |
News Archive
Acerde, an innovative company specializing in the development of rotating anodes for X-ray tubes used in the medical imaging industry, today announced (i) the signature of a development contract with a major China-based player in medical imaging, (ii) its achievement of a number of industrial development milestones and (iii) the preparation of the company's next generation of highly innovative rotating anodes (which are now composite-based rather than graphite-based).
B. Braun Medical Inc. (B. Braun) has announced an expanded agreement with HealthTrust Purchasing Group (HealthTrust) to provide pain management products to HealthTrust's membership.
OncoGenex Pharmaceuticals, Inc. announced today that it has initiated patient enrollment in a randomized, Phase II clinical trial evaluating OGX-427, an inhibitor of heat shock protein 27 (Hsp27), in patients with advanced bladder cancer.
Emerging Healthcare Solutions, Inc. under their exclusive option agreement with Thrombovision, has begun due diligence to aggressively seek the establishment of business opportunities with the new patented T-Guide Platelet Function Analyzer.
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
› Verified 9 days ago
Garden Place Healthcare Location: 193-195 Pleasant Street, Attleboro, Massachusetts 02703 Phone: (508) 222-4950 | |
Life Care Center Of Attleboro Location: 969 Park Street, Attleboro, Massachusetts 02703 Phone: (508) 222-4182 |